What Hepion Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 7 | 12 |
| Sells | 0 | 0 |
| Total trades | 7 | 12 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 49,700,000 | 49,700,000 |
| Disposed | 0 | 0 |
| Net activity | +49,700,000 | +49,700,000 |
Common stock only — 5 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Fisher Danina | Director | Sep 29 | Open-market buy · P | +200,000 | $0.05 | +$10K | 200,000 |
| Stetz Gary S. Ii | Director | Aug 03 | Open-market buy · P | +500,000 | $0.05 | +$25K | 500,000 |
| LoPriore Vincent S | Executive Chairman | Aug 03 | Open-market buy · P | +2,000,000 | $0.05 | +$100K | 16,250,000 |
| LoPriore Vincent S | Executive Chairman | Aug 03 | Open-market buy · P | +8,000,000 | $0.05 | +$400K | 14,250,000 |
| Purcell Michael J. | Director | Aug 03 | Open-market buy · P | +2,000,000 | $0.05 | +$100K | 3,250,000 |
| Appajosyula Sireesh | Chief Operating Officer | Aug 03 | Open-market buy · P | +2,000,000 | $0.05 | +$100K | 3,250,000 |
| Stetz Gary S. | Interim CEO | Aug 03 | Open-market buy · P | +2,000,000 | $0.05 | +$100K | 3,250,000 |
| Stetz Gary S. | Interim CEO | Apr 21 | Open-market buy · P | +1,250,000 | $0.04 | +$50K | 1,250,000 |
| Appajosyula Sireesh | Director | Apr 21 | Open-market buy · P | +1,250,000 | $0.04 | +$50K | 1,250,000 |
| LoPriore Vincent S | Executive Chairman | Apr 21 | Open-market buy · P | +1,250,000 | $0.04 | +$50K | 6,250,000 |
| LoPriore Vincent S | Executive Chairman | Apr 21 | Open-market buy · P | +5,000,000 | $0.04 | +$200K | 5,000,000 |
| Purcell Michael J. | Director | Apr 21 | Open-market buy · P | +1,250,000 | $0.04 | +$50K | 1,250,000 |
| Wijngaard Peter | Director | Nov 27 | Open-market buy · P | +2,500 | $3.05 | +$7.63K | 9,501 |
| Wijngaard Peter | Director | Nov 24 | Open-market buy · P | +2,500 | $3.09 | +$7.73K | 7,001 |
| Wijngaard Peter | Director | Sep 19 | Open-market buy · P | +1,000 | $5.64 | +$5.64K | 4,501 |
| Foster Robert T | CEO and Director | Sep 18 | Open-market buy · P | +1,600 | $5.60 | +$8.96K | 50,470 |
| Foster Robert T | CEO,CSO and Director | Sep 15 | Open-market buy · P | +1,600 | $5.40 | +$8.64K | 48,870 |
| Wijngaard Peter | Director | Sep 15 | Open-market buy · P | +861 | $5.37 | +$4.62K | 3,501 |
| Wijngaard Peter | Director | Sep 15 | Open-market buy · P | +139 | $5.45 | +$758 | 2,640 |
| Wijngaard Peter | Director | Sep 15 | Open-market buy · P | +1,000 | $5.82 | +$5.82K | 2,501 |
Loading...
